Twist Bioscience Corp

Twist Bioscience Corp

TWST

Market Cap$2.28B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Twist Bioscience CorpTwist Bioscience Corp-11.9--43%7.20.2
$47.00

Target Price by Analysts

31.1% upsideTwist Bioscience Target Price DetailsTarget Price
$42.26

Current Fair Value

17.9% upside

Undervalued by 17.9% based on the discounted cash flow analysis.

Share Statistics

Market cap$2.28 Billion
Enterprise Value$2.15 Billion
Dividend Yield$0 (0%)
Earnings per Share$-3.6
Beta2.37
Outstanding Shares59,649,000

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-11.87
PEG87.59
Price to Sales7.17
Price to Book Ratio5.12
Enterprise Value to Revenue6.18
Enterprise Value to EBIT-14.32
Enterprise Value to Net Income-12
Total Debt to Enterprise0.04
Debt to Equity0.18

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Twist Bioscience Corp

CEO: Emily Leproust

Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary techno...